TNF-related activation-induced cytokine (TRANCE), also known as tumor necrosis factor ligand superfamily member 11 (TNFSF11), receptor activator of nuclear factor kappa-B ligand (RANKL), is a member of the TNF superfamily. Cells known to express TRANCE include osteoblasts, CD4 and CD8 T cells, megakaryocytes, bronchial and intestinal epithelium and so on.
TRANCE appears to play a central role in both immune response and bone morphogenesis. During bone development and remodeling, TRANCE expression by osteoblasts in conjunction with M-CSF induces osteoclast formation and activation, resulting in bone resorption. This allows for subsequent bone deposition and remodeling. TRANCE also plays a role in pathological osteoporosis. Its inappropriate expression by activated lymphocytes and osteoblasts results in excessive joint and bone resorption vs. deposition. Overproduction of TRANCE is implicated in a variety of degenerative bone diseases, such as rheumatoid arthritis and psoriatic arthritis.
TRANCE/TNFSF11/RANKL ELISA Kit, Human
$529.00
This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human TRANCE. The Human TRANCE/TNFSF11/RANKL ELISA is for research use only. Not for diagnostic or therapeutic procedures.
Weight | 1 lbs |
---|---|
Dimensions | 8 × 6 × 4 in |
Sensitivity | 0.75 pg/ml |
Standard Curve | 7.81 – 500 pg/ml |
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.